A Safety Study of ARRY-300 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This is a Phase 1 study, involving a 1-day dosing period (up to 3 dosing periods per subject), designed to test the safety of investigational study drug ARRY-300 in healthy subjects. Approximately 12 healthy subjects from the US will be enrolled in this study.
Epistemonikos ID: 6ab39468d6de3593eb4cb093e8bc2ac6fb04b207
First added on: May 05, 2024